BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2448608)

  • 1. Monoclonal antibodies against Vipera lebetina venom nerve growth factor cross-react with other snake venom nerve growth factors.
    Arumäe U; Siigur J; Neuman T; Saarma M
    Mol Immunol; 1987 Dec; 24(12):1295-302. PubMed ID: 2448608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody immunoaffinity chromatography of the nerve growth factor from snake venoms.
    Siigur J; Arumäe U; Neuman T; Siigur E; Saarma M
    Comp Biochem Physiol B; 1987; 87(2):329-34. PubMed ID: 3621902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of nerve growth factor from Vipera berus berus (common viper) venom.
    Siigur J; Arumäe U; Neuman T; Samel M; Siigur E; Saarma M
    Comp Biochem Physiol B; 1986; 83(3):621-5. PubMed ID: 3956173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monoclonal antibodies to the nerve tissue growth factor from Vipera lebetina venom].
    Saarma MIu; Neuman TE; Tal'psep TE; Toots IE; Siĭgur EP
    Dokl Akad Nauk SSSR; 1984; 277(5):1267-9. PubMed ID: 6499649
    [No Abstract]   [Full Text] [Related]  

  • 5. Procoagulant activities in venoms from central Asian snakes.
    Yukelson LY; Tans G; Thomassen MC; Hemker HC; Rosing J
    Toxicon; 1991; 29(4-5):491-502. PubMed ID: 1830705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of nerve growth factor from Vipera lebetina (snake) venom.
    Siigur E; Neuman T; Järve V; Tara A; Siigur J
    Comp Biochem Physiol B; 1985; 81(1):211-5. PubMed ID: 4017541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular diversity of snake venom nerve growth factors.
    Trummal K; Tõnismägi K; Paalme V; Järvekülg L; Siigur J; Siigur E
    Toxicon; 2011 Sep; 58(4):363-8. PubMed ID: 21801740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of nerve growth factors (NGFs) from snake venoms by use of a novel, quantitative bioassay utilizing pheochromocytoma (PC12) cells overexpressing human trkA receptors.
    Katzir I; Shani J; Goshen G; Sela J; Ninary E; Dogonovski AM; Shabashov D; Inoue S; Ikeda K; Hayashi K; Gorinstein S; Deutsch J; Lazarovici P
    Toxicon; 2003 Oct; 42(5):481-90. PubMed ID: 14529729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effect of gamma rays on the venom of Vipera lebetina by biochemical study.
    Bennacef-Heffar N; Laraba-Djebari F
    Can J Physiol Pharmacol; 2003 Dec; 81(12):1110-7. PubMed ID: 14719029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological properties of antivenins. II. Univalent Naja haje antivenin.
    Hassan F; El-Hawary MF
    Am J Trop Med Hyg; 1976 Mar; 25(2):347-50. PubMed ID: 816220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in yield and lethality of venoms from Iranian snakes.
    Latifi M
    Toxicon; 1984; 22(3):373-80. PubMed ID: 6474490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactivities of polyclonal antibodies against factor V activating enzyme, a serine proteinase from Vipera lebetina (snake) venom.
    Siigur E; Samel M; Tõnismägi K; Siigur J
    Comp Biochem Physiol B Biochem Mol Biol; 2000 Jul; 126(3):377-82. PubMed ID: 11007179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-reactivities of polyclonal antibodies against lebetase, fibrinolytic enzyme of Levantine viper (Vipera lebetina) venom.
    Siigur J; Tõnismägi K; Tu AT; Siigur E
    Toxicon; 1996 May; 34(5):608-13. PubMed ID: 8783456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross neutralization of dangerous snake venoms from Africa and the Middle East using the VACSERA polyvalent antivenom. Egyptian Organization for Biological Products & Vaccines.
    Seddik SS; Wanas S; Helmy MH; Hashem M
    J Nat Toxins; 2002 Dec; 11(4):329-35. PubMed ID: 12503876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the nerve growth factor proteins from cobra venom (Naja naja) and mouse submaxillary gland.
    Server AC; Herrup K; Shooter EM; Hogue-Angeletti RA; Frazier WA; Bradshaw RA
    Biochemistry; 1976 Jan; 15(1):35-9. PubMed ID: 813760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies to nerve growth factor from bovine seminal plasma.
    Steele JG; Dalton BA; Hoffman H; Underwood PA; Rathjen D
    Mol Immunol; 1985 Sep; 22(9):1061-72. PubMed ID: 2415811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological and immunological properties of nerve growth factor from snake venoms.
    Lipps BV
    J Nat Toxins; 1998 Jun; 7(2):121-30. PubMed ID: 9678186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on development of Vipera lebetina snake anti-venom in chicken egg yolk for passive immunization.
    Zolfagharian H; Dounighi NM
    Hum Vaccin Immunother; 2015; 11(11):2734-9. PubMed ID: 25700656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of dot-ELISA for the detection of venoms of major Indian venomous snakes.
    Shaikh IK; Dixit PP; Pawade BS; Waykar IG
    Toxicon; 2017 Dec; 139():66-73. PubMed ID: 29024771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of PLA2-s from Vipera lebetina, Vipera berus berus and Naja naja oxiana venom with platelets, bacterial and cancer cells.
    Samel M; Vija H; Kurvet I; Künnis-Beres K; Trummal K; Subbi J; Kahru A; Siigur J
    Toxins (Basel); 2013 Jan; 5(2):203-23. PubMed ID: 23348053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.